Showing 141 - 160 results of 1,509 for search '(( 10 i decrease ) OR ( 5 ((point decrease) OR (((a decrease) OR (mean decrease)))) ))', query time: 0.27s Refine Results
  1. 141
  2. 142

    Deep Reinforcement Learning Powered IRS-Assisted Downlink NOMA by Shehab, Muhammad

    Published 2022
    “…As the imperfection increases by ten times, the rate decreases by more than 10%. 2020 IEEE.…”
    Get full text
    Get full text
  3. 143

    Mitigating Cardiotoxicity of Dendrimers: Angiotensin-(1-7) via Its Mas Receptor Ameliorates PAMAM-Induced Cardiac Dysfunction in the Isolated Mammalian Heart by Akhtar, Saghir

    Published 2022
    “…Herein, we investigated (a) the effect of polyamidoamine (PAMAM) dendrimer generation (G7, G6, G5, G4 and G3) and surface chemistry (-NH2, -COOH and -OH) on cardiac function in mammalian hearts following ischemia-reperfusion (I/R) injury, and (b) determined if any PAMAM-induced cardiotoxicity could be mitigated by Angiotensin-(1-7) (Ang-(1-7), a cardioprotective agent. …”
    Get full text
    Get full text
    Get full text
  4. 144
  5. 145

    An evidence base for school health policy during the covid-19 pandemic by Badran, S.

    Published 2021
    “…Further data suggested decreased childhood transmission from respiratory droplets and a low viral load among children. …”
    Get full text
    Get full text
  6. 146
  7. 147
  8. 148
  9. 149
  10. 150
  11. 151

    Signaling pathways activated by PACAP in MCF-7 breast cancer cells by Zibara, Kazem

    Published 2018
    “…Results showed that MCF-7 cells express VPAC1 and VPAC2, but not PAC1, receptors. In addition, PACAP increased the phosphorylation levels of STAT1, Src and Raf within seconds, confirming their involvement in early stages of PACAP signaling whereas maximal phosphorylation of AKT, ERK and p38 was reached 10 to 20 min later. …”
    Get full text
    Get full text
  12. 152
  13. 153

    Evaluating the effect of glycaemic control, blood pressure, lipid profile and diabetes duration on developing diabetes complications and its progression by Albaroodi K.A.I.

    Published 2018
    “…As the disease duration increases there were a decrease in the number of patients with no complications and an increment in the number of patients with a number of complications. …”
    Get full text
  14. 154

    A Model For A Narrow-Cut Fractionating Column by Farag, Hassan A.

    Published 1997
    “…A mathematical model was developed to simulate the operation of a narrow-cut fractionating column. …”
    Get full text
  15. 155
  16. 156
  17. 157
  18. 158

    MYD88, IRAK3 and Rheumatoid Arthritis pathogenesis: Analysis of differential gene expression in CD14 + monocytes and the inflammatory cytokine levels. by Gomes da Silva, Isaura Isabelle Fonseca

    Published 2021
    “…Two molecular players act in the inflammation balance of the disease: MyD88 (Myeloid differentiation primary response 88) is related to TLR (Toll-like receptors) response and promotes the formation of myddosome complex resulting in increased inflammation; IRAK3 (Interleukin-1 receptor associated kinase 3) acts suppressing the myddosome complex thus decreasing inflammation. …”
    Get full text
    Get full text
  19. 159

    Tailoring the deposition of MoSe2 on TiO2 nanorods arrays via radiofrequency magnetron sputtering for enhanced photoelectrochemical water splitting by Ahmad, Yahia H.

    Published 2023
    “…Compared to pure TiO2 NRs, the heterojunction nanostructured assembly displayed excellent spectral and photoelectrochemical properties, including more surface oxygen vacancies, enhanced visible-light absorption, higher photocurrent response, and decreased charge transfer resistance. In particular, the sample synthesized by sputtering of MoSe2 for 90 s, i.e., MoSe2@TiO2-90 s, depicted the highest current density (1.86 mA cm−2 at 0.5 V vs. …”
    Get full text
    Get full text
  20. 160

    Exploring Beyond Numeric Weight Loss: The Metabolic Effects of Semaglutide. by Sara, Sokary

    Published 2025
    “…Also, it enhanced glycemic control, as evidenced by significant reductions in hemoglobin A1C (HbA1c) with the 0.5 mg and 1.0 mg doses. From a baseline range of 8.1–8.7%, 0.5mg dose lowered HbA1c by 1.2–1.5%, while the 1.0 mg dose reduced it by 1.4–1.8%. …”
    Get full text
    Get full text
    Get full text
    article